Originally published In Press as doi:10.1074/mcp.M300134-MCP200 on January 21, 2004.
Molecular & Cellular Proteomics 3:410-419, 2004.
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Expression of the Tumor Suppressor Protein 14-3-3 Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition*
José M. A. Moreira ,
Pavel Gromov and
Julio E. Celis
From the Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
The 14-3-3 proteins constitute a family of abundant, highly conserved and broadly expressed acidic polypeptides that are involved in the regulation of various cellular processes such as cell-cycle progression, cell growth, differentiation, and apoptosis. One member of this family, the 14-3-3 isoform , is expressed only in epithelial cells and is frequently down-regulated in a variety of human cancers. To determine the prevalence of 14-3-3 silencing in bladder cancer progression, we have studied the expression of this protein in normal urothelium and bladder transitional cell carcinomas (TCCs) of various grades and stages using two-dimensional gel electrophoresis in combination with Western blotting and immunohistochemistry. We show that the expression of 14-3-3 is down-regulated in invasive TCCs, particularly in lesions that are undergoing epithelial-to-mesenchymal conversion. Altered expression of 14-3-3 in invasive TCCs is not due to increased externalization of the protein nor to an aberrant proliferative potential of neoplastic cells. Furthermore, we found that impaired 14-3-3 expression is not associated with increased levels of the dominant-negative transcriptional regulator Np63. Down-regulation of 14-3-3 was confirmed by indirect immunofluorescence using a peptide-based rabbit polyclonal antibody specific for this protein. We also show that the expression of 14-3-3 is highly up-regulated in pure squamous cell carcinomas. Taken together, these results provide evidence that deregulation of 14-3-3 may play a key role in bladder cancer progression, in particular in differentiation events leading to epithelial-to-mesenchymal transition and stratified squamous metaplasia.
To whom correspondence should be addressed: Department of Proteomics in Cancer, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark. Tel.: 45-35257500; Fax: 45-35257721; E-mail: jom{at}cancer.dk and jec{at}cancer.dk

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Sun, S. Zhang, D. Zhang, Y. Li, X. Zhao, Y. Luo, and Y. Guo
Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer
Clin. Cancer Res.,
November 1, 2008;
14(21):
7050 - 7059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. A. Moreira, T. Shen, G. Ohlsson, P. Gromov, I. Gromova, and J. E. Celis
A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences
Mol. Cell. Proteomics,
July 1, 2008;
7(7):
1225 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Suzuki, H. Watanabe, T. Mizutani, T. Sato, Y. Ohta, and T. Iguchi
Global Gene Expression in Mouse Vaginae Exposed to Diethylstilbestrol at Different Ages.
Experimental Biology and Medicine,
May 1, 2006;
231(5):
632 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, T. Suzuki, J.-i. Akahira, M. Sakuma, S. Saitou, S. Okamoto, H. Niikura, K. Okamura, N. Yaegashi, H. Sasano, et al.
14-3-3{sigma} in Endometrial Cancer-A Possible Prognostic Marker in Early-Stage Cancer
Clin. Cancer Res.,
October 15, 2005;
11(20):
7384 - 7391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Faul, S. Huttelmaier, J. Oh, V. Hachet, R. H. Singer, and P. Mundel
Promotion of importin {alpha}-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3
J. Cell Biol.,
May 9, 2005;
169(3):
415 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis
Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast
Mol. Cell. Proteomics,
April 1, 2005;
4(4):
555 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Celis, P. Gromov, T. Cabezon, J. M. A. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova
Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment: A Novel Resource for Biomarker and Therapeutic Target Discovery
Mol. Cell. Proteomics,
April 1, 2004;
3(4):
327 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|